High prevalence of extended‐spectrum beta‐lactamase organisms and the COVID‐19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong-Reference-Cited by-同舟云学术

High prevalence of extended‐spectrum beta‐lactamase organisms and the COVID‐19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong

Published:2021-10-08 Issue:9 Volume:9 Page:1027-1038
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Yau Yuk Kam¹²^ORCID,Mak Wing Yan Joyce¹²^ORCID,Lui Nok Shun Rashid²,Ng Wai Yin Rita¹³,Cheung Choi Yan Kitty¹²,Li Ying Lee Amy¹²,Ching Yuet Ling Jessica¹²,Chin Miu Ling¹³,Lau Ho Shing Louis²,Chan Ka Leung Francis¹²⁴,Chan Kay Sheung Paul¹³,Ng Siew Chien¹²⁴^ORCID

Affiliation:

1. Center for Gut Microbiota Research Faculty of Medicine The Chinese University of Hong Kong Hong Kong China

2. Department of Medicine & Therapeutics Faculty of Medicine The Chinese University of Hong Kong Hong Kong China

3. Department of Microbiology Faculty of Medicine The Chinese University of Hong Kong Hong Kong China

4. LKS Institute of Health Science The Chinese University of Hong Kong Hong Kong China

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ueg2.12160

Reference55 articles.

1. Fecal microbiota transplantation: in perspective

2. Faecal microbiota transplantation for treatment of recurrent or refractory Clostridioides difficile infection in Hong Kong;Lui RN;Hong Kong Med J,2019

3. Duodenal Infusion of Donor Feces for RecurrentClostridium difficile

4. Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

5. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fecal Microbiota Transplantation for Sleep Disturbance in Post-acute COVID-19 Syndrome;Clinical Gastroenterology and Hepatology;2024-06

2. Assuring safety of fecal microbiota transplantation in the COVID‐19 era: A single‐center experience;JGH Open;2023-10-20

3. Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea;Alimentary Pharmacology & Therapeutics;2023-09-05

4. Long-Term Safety Outcomes of Fecal Microbiota Transplantation: Real-World Data Over 8 Years From the Hong Kong FMT Registry;Clinical Gastroenterology and Hepatology;2023-09

5. COVID-19 pandemic impact on antibiotics sensitivity of E. coli and K. pneumoniae from urine specimens: a retrospective study;The Journal of Infection in Developing Countries;2023-08-31